-
Legendary Creatures has teamed up with Noile-Immun
Time of Update: 2021-03-06
Founded in April 2015 in Tokyo, Japan, Noile-Immune is a clinical-stage biotechnology company focused on the development and commercialization of solid tumor CAR-T therapies, and its PRIME technology promotes the amplification, accumulation and induction of CAR-T and/or TCR-T cells and the patient's own T-cells in solid tumors.
-
Getting rid of "foreign evidence" China's new drugs need to be developed collectively
Time of Update: 2021-02-06
Dr. Liu Shengjiang, chief scientist at Bayer Pharmaceuticals, said that if it were a new drug developed by China itself, the drug manual would naturally be based on "Chinese evidence", and that many of the drugs currently on the market abroad would be introduced into China.
-
New crown virus research findings have been released in many countries
Time of Update: 2021-01-22
November 30, 2020, CDC researchers report in the semi-monthly journal Clinical Infectious Diseases that new coronavirus antibodies were present in blood donation samples from some Americans in December 2019, meaning that the new coronavirus may have appeared in the United States by then, earlier than the first confirmed case of new coronary pneumonia officially reported in the United States -- January 21, 2020.
-
2020 NEJM Weight Study Inventory TOP10 Mays reviewed
Time of Update: 2021-01-02
This report is the full version of the data, which is an ongoing cross-border, placebo-controlled, observer-blind, key efficacy trial in which people aged 16 years or older were randomly assigned a 1:1 ratio to receive two placebos or BNT162b2 at 21-day intervals.
-
Cover article published! The latest findings of Xinda Bio's new TIM-3 monoantitonic resistance have been published
Time of Update: 2020-12-24
Therefore, there is a clinically urgent need for other co-inhibitory bodies that can work together with PD-1 or CTLA-4 to inhibit T-cell responses, or other co-inhibitors that play a major negative role in the regulation of certain tumor types of immune response, tim-3 is one of them.
-
The giant Pandora virus specializes in creating new genes
Time of Update: 2020-12-19
have discovered three new Pandora's viruses and found that they have many "orphan genes" in their vast genomes.
in their paper, published in the British journal , they say the viruses come from very different sources and are similar in form and function, but the genome is not very similar, and only half of the genes that encode proteins are the same.
-
Cell interpretation! Identify new antigen targets for tumors to develop new anti-cancer immunotherapy
Time of Update: 2020-11-27
Nov 23, 2020 // -- Cancer neoantigens, a cancer neoantigens that target tumor-specific soy cell mutations, may be a very attractive and challenging strategy for specifically removing tumor cells throu
-
Lancet: 369 diseases, 87 risk factors Which are most associated with death and disability
Time of Update: 2020-11-01
, this is one of the most comprehensive global studies, analyzing 286 causes of death, 369 diseases and injuries, and 87 risk factors in 204 countries and territories, according to the press release.
-
Annual output of 110,000 tons, polyester resin elite power powder enterprises set sail
Time of Update: 2020-10-05
research and development strength, to provide strong technical support Fenglin new materials to cultivate a chief industry experts led by more than 20 high-quality professional research and development team, and has an international advanced level of central program control system and a series of high-precision polyester resin testing equipment and instruments, not only can greatly shorten the product development cycle, accelerate product upgrading, but also through fine management to meet customer interests and needs.
-
A batch of large varieties will be restricted to use Non-conformity will be cleared out of the catalog
Time of Update: 2020-08-26
When the "restricted use" requirements of anti-tumor drugs are further clarified, a large number of drugs may be included in the list of priority regulation and restricted use in the future ... Recen
-
Yuanqi forest, Zhong Xuegao, Hua Xizi... Consumption upgrades under the new national goods to create heroes
Time of Update: 2020-08-18
especially in the fast-consumer industry, the current main group is after 95 00, their personality preferences, values orientation and internal emotional appeal, determine the direction of the development of the brand.
-
International oil prices exceed $120 for the first time in the 5th
Time of Update: 2020-07-03
, May 5 (Xinhua) -- International oil prices rose sharply on Friday, with the price of oil in New York hitting an intraday high of $120.36 due to concerns about tight supplies the main reason for the
-
Catastrophe not a single line: Dentons' poor performance - losing the case
Time of Update: 2020-06-30
house leakage is the night rain, the ship late and hit the head wind again 4Gx On March 25, 2014, Dentons Group issued two announcements, one for warning of further adverse effects on earnings, an
-
New York to introduce new paint recycling regulations
Time of Update: 2019-12-27
new law, which was overwhelmingly approved by the state legislature and signed by New York Gov Andrew Cuomo on December 18, will soon be able to recycle unwanted paint thanks to a new law More than
-
"Pharmaceutical leader" is the world's first car-t therapy approved for health insurance TPA investment in China
Time of Update: 2019-10-31
The only difference is everywhere The end of adjuvant medicine has come.
